Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis

Background: Clinical practice guidelines for the treatment of idiopathic pulmonary fibrosis (IPF) currently recommend pirfenidone and nintedanib. However, there is a lack of evidence from head-to-head comparisons. Objectives: To perform a systematic review and network meta-analysis (NMA) to access t...

Descripción completa

Detalles Bibliográficos
Autores principales: Skandamis, Aristeidis, Kani, Chara, Markantonis, Sophia L., Souliotis, Kyriakos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484486/
https://www.ncbi.nlm.nih.gov/pubmed/31044096
http://dx.doi.org/10.1080/21556660.2019.1597726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484486/
https://www.ncbi.nlm.nih.gov/pubmed/31044096
http://dx.doi.org/10.1080/21556660.2019.1597726

Ejemplares similares